PR
ProKidney
PROK·NASDAQWinston-Salem NCFounded 202240 employees
Micro CapbiotechPublicNephrology
Platform: Cell Ther CKD
Market Cap
$0.1B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (PROK)
Loading PROK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zenoglumide | PRO-3477 | Preclinical | 2 | Cl18.2 | FTDCrohn's | ||
| Tixafutibatinib | PRO-3550 | Phase 1/2 | 2 | USP1 | Parkinson'sCervical Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)